跳至主要内容
临床试验/NL-OMON47855
NL-OMON47855已完成2 期

Visualizing beta cells after Intrahepatic Islet of Langerhans Transplantation - Visualizing beta cells after islet transplantation

Radboud Universitair Medisch Centrum0 个研究点目标入组 13 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - > 18 years old
  • - T1D patient undergone islet transplantation
  • - Clinically proven functional islet graft (stimulated C-peptide > 0.8 nmol/L)
  • - Signed informed consent
  • Inclusion criteria T1D patients without an islet transplant
  • - > 18 years old
  • - Signed informed consent;on the waiting list for islet transplantation

排除标准

  • - Treatment with synthetic Exendin (Exenatide, Byetta®) or Dipeptidyl-Peptidase IV inhibitors within the last 3 months
  • - Breast feeding
  • - Pregnancy or the wish to become pregnant within 6 months
  • - Affected kidney function * Calculated creatinine clearance below 30ml/min
  • - Liver disease defined as aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range (45 U/L).
  • - Age < 18 years
  • - No signed informed consent
  • - Exclusion criteria for MR:
  • * Metallic fragments, clips or devices in brain, eyes, spinal canal
  • * Implantable defibrillator or pacemaker (wires)
  • * Mandibular magnetic implants
  • * Neurostimulator, bladder stimulator, non-removable insulin pump
  • * Metal tissue-expander in chest
  • * Cochlear implant
  • * Ossicular replacement prosthesis

研究者

相似试验

Visualizing beta cells after Intrahepatic Islet of... | 临床试验